Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Change in Accured Expenses (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Change in Accured Expenses for 5 consecutive years, with $120000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Change in Accured Expenses fell 24.05% to $120000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was -$3.2 million, a 1276.1% decrease, with the full-year FY2024 number at $109000.0, down 41.4% from a year prior.
  • Change in Accured Expenses was $120000.0 for Q4 2020 at Forte Biosciences, up from $33000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.1 million in Q4 2018 to a low of -$3.7 million in Q2 2020.
  • A 5-year average of $284650.0 and a median of $139000.0 in 2019 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: soared 2052.23% in 2018, then plummeted 847.78% in 2019.
  • Forte Biosciences' Change in Accured Expenses stood at $214000.0 in 2016, then crashed by 173.36% to -$157000.0 in 2017, then skyrocketed by 2052.23% to $3.1 million in 2018, then plummeted by 94.85% to $158000.0 in 2019, then fell by 24.05% to $120000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Change in Accured Expenses are $120000.0 (Q4 2020), $33000.0 (Q3 2020), and -$3.7 million (Q2 2020).